WHO guidance for best practices for clinical trials – Health Research BC

Clinical trials have a central role in generating the evidence needed to inform the development and implementation of health interventions. This is because they can reliably determine whether a health intervention has any effect by ensuring that any biases or random errors inherent in the study design are small with respect to the expected treatment effect. The results have been transformative in advancing global public health.

The intent of the ‘World Health Organization guidance for best practices for clinical trials’ document is to support implementation of universal ethical and scientific standards and strengthen the clinical trial ecosystem, with a focus on under-represented populations. It is also complementary to other good clinical practice initiatives.

Join us for an overview presentation on the WHO document which spans all regions and nations and is applicable across all health product lines: any design, health intervention, purpose, setting and role.

Learn more here